Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2007-05-25FDA Approved: XYZAL — Original Application (Chattem, Inc.)
The FDA approved the original application for XYZAL (levocetirizine dihydrochloride) by Chattem, Inc., for the treatment of allergic rhiniti…
-
CLINICAL_TRIALS research · 2007-05-07Clinical Trial Update: Randomised Controlled Clinical Trials of the Effect of Therapeutic Hookworm Infection in Allergic Rhinoconjunctivitis [NA]
Completed randomized controlled trials evaluating whether inducing hookworm infection can modify symptoms of allergic rhinitis (hay fever).
-
FDA approval · 2007-04-27FDA Approved: FLONASE SENSIMIST ALLERGY RELIEF — Original Application (Haleon US Holdings LLC)
FDA approved FLONASE SENSIMIST ALLERGY RELIEF (fluticasone furoate) under an original NDA from Haleon US Holdings LLC for relief of symptoms…
-
FDA approval · 2007-04-16FDA Approved: LORATADINE ALLERGY RELIEF — Supplemental Application (DISCOUNT DRUG MART)
FDA approved a supplemental application for Loratadine Allergy Relief, a loratadine 10 mg product from Discount Drug Mart, enabling its mark…
-
FDA approval · 2007-04-11FDA Approved: ALLERGY RELIEF — Original Application (Ohm Laboratories Inc.)
The FDA approved Ohm Laboratories Inc.'s original ANDA for ALLERGY RELIEF, a generic loratadine product. This marks approval of a generic an…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-03-23FDA Approved: LORATADINE ALLERGY RELIEF — Supplemental Application (DISCOUNT DRUG MART)
The FDA approved a supplemental application for LORATADINE ALLERGY RELIEF from Discount Drug Mart, under an existing ANDA.
-
FDA approval · 2007-01-25FDA Approved: CAREONE ALLERGY RELIEF — Supplemental Application (American Sales Company)
The FDA approved a supplemental application for CAREONE ALLERGY RELIEF containing fexofenadine hydrochloride (Fexofenadine HCl) submitted by…
-
CLINICAL_TRIALS trial_result · 2006-12-19Clinical Trial Update: Efficacy and Safety of Subcutaneous Immunotherapy in Birch Pollen Allergic Patients [Phase 2]
A Phase 2 trial evaluating subcutaneous immunotherapy for birch pollen allergy was terminated; the update discusses efficacy and safety obse…
-
FDA label_change · 2006-12-14FDA Approved: CLARINEX — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for CLARINEX (desloratadine) from Organon LLC. The approval updates the product labeling.
-
FDA approval · 2006-12-12FDA Approved: CLARITIN REDITABS — Original Application (Bayer HealthCare LLC)
FDA approved Claritin RediTabs (loratadine) from Bayer in its original application; an antihistamine indicated for relief of symptoms of all…
-
FDA approval · 2006-12-08FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast) by Organon LLC.
-
FDA approval · 2006-12-07FDA Approved: PROMETHAZINE HYDROCHLORIDE AND PHENYLEPHRINE HYDROCHLORIDE — Original Application (Genus Lifesciences Inc.)
FDA approved Genus Lifesciences' original application for a generic promethazine hydrochloride and phenylephrine hydrochloride product, a co…
-
CLINICAL_TRIALS trial_result · 2006-11-07Clinical Trial Update: Effect of Omalizumab (Xolair) in Treatment of Patients With AERD and Allergy Asthma [NA]
Clinical trial evaluating the effect of omalizumab (Xolair) in patients with aspirin-exacerbated respiratory disease and allergic asthma; cu…
-
FDA approval · 2006-10-20FDA Approved: OMNARIS — Original Application (Covis Pharma US, Inc)
FDA approved Omnaris (ciclesonide nasal spray) via an Original Application from Covis Pharma US, marking the first FDA approval of this prod…
-
CLINICAL_TRIALS trial_result · 2006-08-29Clinical Trial Update: A Trial of Point of Care Information in Ambulatory Pediatrics [Phase 3]
A Phase 3 clinical trial evaluating a point-of-care information tool in ambulatory pediatrics has completed.
-
FDA approval · 2006-08-23FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Original Application (Bayer HealthCare LLC.)
FDA approved a chewable grape and bubblegum formulation of loratadine (Claritin) under an Original Application by Bayer HealthCare LLC. This…
-
FDA approval · 2006-07-31FDA Approved: PROMETHAZINE HYDROCHLORIDE — Original Application (KVK-Tech, Inc.)
The FDA approved KVK-Tech, Inc.'s original application for promethazine hydrochloride, establishing a generic product. This approval confirm…
-
FDA approval · 2006-07-07FDA Approved: CAREONE ALLERGY RELIEF — Supplemental Application (American Sales Company)
FDA approves a supplemental application for CAREONE ALLERGY RELIEF (fexofenadine HCl) from American Sales Company.
-
FDA approval · 2006-06-30FDA Approved: FLUTICASONE PROPIONATE — Original Application (Cosette Pharmaceuticals, Inc.)
FDA approved the original application for Fluticasone Propionate from Cosette Pharmaceuticals, Inc. as a generic product.
-
FDA approval · 2006-06-29FDA Approved: LORATADINE — Original Application (Lannett Company, Inc.)
FDA approved a generic loratadine as an Original Application for Lannett Company, Inc.
-
FDA approval · 2006-06-07FDA Approved: CARBZAH — Supplemental Application (IPG Pharmaceuticals, inc.)
The FDA approved a supplemental application for CARBZAH (carbinoxamine maleate) from IPG Pharmaceuticals, Inc., indicating regulatory approv…
-
CLINICAL_TRIALS trial_result · 2006-05-04Clinical Trial Update: Tolerability of Grazax-R in Children [Phase 1]
Phase 1 tolerability study of Grazax-R in pediatric patients with allergy has completed.
-
CLINICAL_TRIALS trial_result · 2006-05-04Clinical Trial Update: Tolerability of ALK Grass Tablet in Children [Phase 1]
Phase 1 tolerability study of ALK Grass Tablet in children is summarized; the update covers tolerability findings from the early trial.